EE200200032A - Interleukiin-18 inhibiitorite kasutamine metastaaside pärssimiseks sobivate ravimite valmistamiseksning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon - Google Patents

Interleukiin-18 inhibiitorite kasutamine metastaaside pärssimiseks sobivate ravimite valmistamiseksning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon

Info

Publication number
EE200200032A
EE200200032A EEP200200032A EEP200200032A EE200200032A EE 200200032 A EE200200032 A EE 200200032A EE P200200032 A EEP200200032 A EE P200200032A EE P200200032 A EEP200200032 A EE P200200032A EE 200200032 A EE200200032 A EE 200200032A
Authority
EE
Estonia
Prior art keywords
inhibitors
metastases
interleukin
medicines
inhibition
Prior art date
Application number
EEP200200032A
Other languages
English (en)
Inventor
Dinarello Charles
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200200032A publication Critical patent/EE200200032A/et
Publication of EE04838B1 publication Critical patent/EE04838B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200032A 1999-07-22 2000-07-17 Interleukiin-18 inhibiitorite kasutamine kasvaja metastaaside pärssimiseks sobivate ravimite valmistamiseks ning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon EE04838B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (2)

Publication Number Publication Date
EE200200032A true EE200200032A (et) 2003-02-17
EE04838B1 EE04838B1 (et) 2007-06-15

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200032A EE04838B1 (et) 1999-07-22 2000-07-17 Interleukiin-18 inhibiitorite kasutamine kasvaja metastaaside pärssimiseks sobivate ravimite valmistamiseks ning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon

Country Status (31)

Country Link
US (1) US7741276B2 (et)
EP (1) EP1206274B1 (et)
JP (1) JP4827352B2 (et)
KR (1) KR100682219B1 (et)
CN (1) CN1173736C (et)
AR (1) AR024907A1 (et)
AT (1) ATE363288T1 (et)
AU (1) AU782478B2 (et)
BG (1) BG65800B1 (et)
BR (1) BR0012675A (et)
CA (1) CA2380216C (et)
CY (1) CY1107932T1 (et)
CZ (1) CZ302114B6 (et)
DE (2) DE60035049T2 (et)
DK (1) DK1206274T3 (et)
EA (1) EA005419B1 (et)
EE (1) EE04838B1 (et)
ES (1) ES2186596T3 (et)
HK (1) HK1048248B (et)
HU (1) HU228780B1 (et)
IL (2) IL131047A0 (et)
MX (1) MXPA02000838A (et)
NO (1) NO329827B1 (et)
NZ (1) NZ516535A (et)
PL (1) PL202477B1 (et)
PT (1) PT1206274E (et)
SK (1) SK287522B6 (et)
TR (1) TR200200169T2 (et)
UA (1) UA73745C2 (et)
WO (1) WO2001007480A2 (et)
ZA (1) ZA200200390B (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356836A1 (en) 2000-02-10 2004-07-12 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
AU1174402A (en) 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
CN100556450C (zh) * 2001-05-16 2009-11-04 耶达研究发展有限公司 Il-18抑制剂在治疗或预防脓毒症中的应用
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
US7279155B2 (en) * 2002-10-08 2007-10-09 Ares Trading S.A. Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
AU2023236289A1 (en) 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
JP2026503273A (ja) 2023-01-06 2026-01-28 ラッセン・セラピューティクス・インコーポレイテッド 抗ｉｌ－１８ｂｐ抗体
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT69922A (en) * 1992-09-02 1995-09-28 Isis Pharmaceuticals Inc Oligonucleotide modification of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
IL131047A0 (en) 2001-01-28
HU228780B1 (en) 2013-05-28
AU5843200A (en) 2001-02-13
KR20020027493A (ko) 2002-04-13
SK287522B6 (sk) 2011-01-04
ES2186596T1 (es) 2003-05-16
DE60035049T2 (de) 2007-09-27
NO329827B1 (no) 2011-01-03
DE60035049D1 (de) 2007-07-12
EP1206274A2 (en) 2002-05-22
HUP0202107A3 (en) 2005-01-28
MXPA02000838A (es) 2002-07-30
NZ516535A (en) 2004-04-30
BG65800B1 (bg) 2009-12-31
WO2001007480A2 (en) 2001-02-01
US7741276B2 (en) 2010-06-22
JP2003505472A (ja) 2003-02-12
CA2380216C (en) 2012-01-31
DE1206274T1 (de) 2002-11-14
EP1206274B1 (en) 2007-05-30
ATE363288T1 (de) 2007-06-15
CA2380216A1 (en) 2001-02-01
NO20020153L (no) 2002-03-11
KR100682219B1 (ko) 2007-02-12
PL202477B1 (pl) 2009-06-30
EE04838B1 (et) 2007-06-15
EA200200189A1 (ru) 2002-12-26
IL147675A (en) 2009-05-04
CN1173736C (zh) 2004-11-03
CZ2002195A3 (cs) 2002-06-12
CY1107932T1 (el) 2013-09-04
BR0012675A (pt) 2002-04-09
AR024907A1 (es) 2002-10-30
HK1048248A1 (en) 2003-03-28
TR200200169T2 (tr) 2002-06-21
UA73745C2 (en) 2005-09-15
CN1364086A (zh) 2002-08-14
AU782478B2 (en) 2005-08-04
PL353732A1 (en) 2003-12-01
BRPI0012675B8 (et) 2021-05-25
EA005419B1 (ru) 2005-02-24
WO2001007480A3 (en) 2001-05-10
JP4827352B2 (ja) 2011-11-30
BRPI0012675B1 (pt) 2001-02-01
HUP0202107A2 (en) 2002-10-28
NO20020153D0 (no) 2002-01-11
DK1206274T3 (da) 2007-08-13
BG106311A (en) 2002-08-30
ES2186596T3 (es) 2007-11-16
SK882002A3 (en) 2002-07-02
PT1206274E (pt) 2007-07-06
ZA200200390B (en) 2003-04-30
US20080003216A1 (en) 2008-01-03
CZ302114B6 (cs) 2010-10-20
HK1048248B (zh) 2005-04-22

Similar Documents

Publication Publication Date Title
ATE503462T1 (de) Pharmazeutische zusammensetzungen mit cholesteryl ester transfer protein inhibitoren
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
HUP0400327A3 (en) Azole derivatives having metalloproteinase inhibitor effect pharmaceutical compositions containing them and their use
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
HUP0400206A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
IL128942A0 (en) Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and pharmaceutical compositions containing the same
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
HUP0105113A3 (en) Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
PL352282A1 (en) Derivatives of thiazoles and pharmaceutical compositions containing these derivatives
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
HUP0302485A3 (en) Arylmethylamine derivatives for use as tryptase inhibitors and pharmaceutical compositions containing them
HUP0104768A3 (en) 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
HUP0301472A3 (en) Carbamate caspase inhibitors and uses thereof and pharmaceutical compositions containing them
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
DE69915144D1 (de) Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen
HUP0302160A3 (en) Pharmaceutical compositions containing the combination of gaba agonists and sorbitol dehydrogenase inhibitors
DK1210119T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka

Legal Events

Date Code Title Description
HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231